Equity firm Excellere wraps up MTS Medication Technologies deal
Written on December 29, 2009
MTS Medication Technologies Inc. is now a privately owned company, after completing its merger with an affiliate of Denver's Excellere Partners LLC.
As a result, MTS common stock no longer is traded on the NASDAQ stock market.
Excellere, a private equity firm, agreed to pay $5.75 a share for all the common stock of MTS in a deal that had a maximum value of $38.8 million.
MTS shareholders with stock certificates will receive instructions in the mail on how and where to forward their certificates for payment, a release said wired payday loan. Brokers or banks that hold MTS shares in “street name†for stockholders will have information on surrendering the shares.
MTS, headquartered in St. Petersburg, Fla., manufactures automated packaging machines and related consumables for prescription medications and nutritional supplements.
Filed in: legal.